For subscribers
Indian firm steps in to ensure long-term supply of malaria vaccine
Sign up now: Get insights on Asia's fast-moving developments
Bharat Biotech will receive manufacturing rights of the RTS,S antigen component from pharmaceutical company GSK.
PHOTO: REUTERS
Follow topic:
KOLKATA - India's vaccine production capacity has come in for praise from various quarters as the world seeks to vaccinate its way out of the Covid-19 pandemic.
Last month, UN Secretary-General António Guterres even described it as "one of the best assets the world has today" as he lauded India for supplying Covid-19 vaccine doses to various nations to support their fight against the coronavirus.
